Table 4 Cell metabolic activity data in the presence of the title phosphonates and their comparison to naturally occuring PCTs and doxorubicin.
Compound | Relative metabolic activity of MG-63 cells at given concentrations of PCTs | Relative metabolic activity of MC3T3-E1 cells at given concentrations of PCTs | ||||
|---|---|---|---|---|---|---|
50 µM | 25 µM | 10 µM | 50 µM | 25 µM | 10 µM | |
Betulinic acid | 1.12 ± 0.08 | 0.91 ± 0.14 | 0.74 ± 0.16 | 0.97 ± 0.07 | 0.56 ± 0.04 | 0.76 ± 0.07 |
Betulonic acid (2a) | 0.88 ± 0.08 | 0.96 ± 0.04 | 1.14 ± 0.02 | 1.22 ± 0.01 | 1.70 ± 0.05 | 1.39 ± 0.06 |
7a | 1.09 ± 0.04 | 1.30 ± 0.06 | 1.10 ± 0.04 | 1.13 ± 0.03 | 1.27 ± 0.05 | 1.41 ± 0.01 |
8a | 1.59 ± 0.17 | 1.24 ± 0.25 | 1.58 ± 0.05 | 1.01 ± 0.05 | 1.19 ± 0.04 | 1.08 ± 0.05 |
Oleanolic acid (1b) | 1.29 ± 0.11 | 1.58 ± 0.13 | 0.77 ± 0.14 | 0.96 ± 0.05 | 0.97 ± 0.08 | 1.04 ± 0.07 |
Oleanonic acid (2b) | 1.03 ± 0.18 | 1.60 ± 0.03 | 1.51 ± 0.08 | 0.49 ± 0.12 | 0.99 ± 0.05 | 1.10 ± 0.01 |
7b | 1.19 ± 0.05 | 1.32 ± 0.05 | 1.13 ± 0.08 | 1.04 ± 0.05 | 1.50 ± 0.04 | 1.31 ± 0.08 |
8b | 0.73 ± 0.05 | 0.76 ± 0.04 | 0.84 ± 0.04 | 0.86 ± 0.08 | 0.97 ± 0.04 | 1.00 ± 0.03 |
Ursolic acid (1c) | 0.28 ± 0.04 | 0.64 ± 0.03 | 0.66 ± 0.03 | 0.99 ± 0.08 | 0.83 ± 0.05 | 1.06 ± 0.05 |
Ursonic acid (2c) | 0.67 ± 0.04 | 0.67 ± 0.04 | 0.76 ± 0.08 | 0.72 ± 0.09 | 1.07 ± 0.07 | 0.74 ± 0.02 |
7c | 1.12 ± 0.03 | 0.98 ± 0.04 | 0.96 ± 0.04 | 0.94 ± 0.05 | 0.90 ± 0.03 | 0.91 ± 0.06 |
8c | 1.26 ± 0.08 | 0.91 ± 0.05 | 1.22 ± 0.09 | 0.95 ± 0.03 | 0.89 ± 0.04 | 0.93 ± 0.09 |
12 | 0.94 ± 0.04 | 0.89 ± 0.05 | 0.97 ± 0.08 | 0.92 ± 0.04 | 0.93 ± 0.06 | 0.90 ± 0.07 |
Doxorubicin | 0.16 ± 0.02 | 0.19 ± 0.01 | 0.41 ± 0.02 | 0.53 ± 0.03 | 0.60 ± 0.03 | 0.72 ± 0.07 |
Positive control | 1.42 ± 0.03 | 1.10 ± 0.10 | ||||
Negative control | 0.16 ± 0.08 | 0.28 ± 0.12 | ||||